The latest from Faes Farma


June 10th, 2025

Faes Farma Acquires SIFI: A Transformational Step Aligned With 2030 Ambitions and Strategy


This acquisition consolidates Faes Farma as a leader in ophthalmology, incorporating a broad portfolio in this key therapeutic area. It enhances the Group’s international expansion, facilitating direct entry into new European markets. […]



More info

March 25th, 2025

Faes Farma signs an agreement to acquire Laboratorios Edol, a leader in ophthalmology in Portugal


Ophthalmology represents a key strategic opportunity for Faes Farma as it is a therapeutic area with expected double-digit growth. This milestone reinforces Faes Farma’s international growth strategy and consolidates its position in […]



More info

All the news